China News Service, July 23. Recently, some media released news such as "some medicines will be transferred to the local medical insurance catalogue at the end of the year", which has aroused certain social concerns.
The official website of the National Medical Insurance Bureau responded on the 23rd that the National Medical Insurance Bureau has researched and formulated a three-year "digestion" plan for local supplementary drugs, that is, starting from 2020, according to the first year 40%, the second year 40%, the third year 20% The proportion of drugs that have been increased in accordance with the regulations in the original provincial drug catalog will be gradually transferred, and by the end of 2022, the scope of national medical insurance will be basically unified.
In response to some netizens claiming that "the local government removed some medicines from the medical insurance catalogue because the medical insurance fund is not enough", the National Medical Insurance Bureau responded that in 2021, the national basic medical insurance fund (including maternity insurance) will have an income of 2.88 trillion yuan and an expenditure of 24,000 yuan. billion.
In general, the national medical insurance fund has a balance of revenue and expenditure, with a slight surplus
. The scale of revenue and expenditure is in line with the level of economic development, and the fund's security capability is stable and sustainable.
In fact, it is precisely under the strong protection of the medical insurance fund that since the establishment of the National Medical Insurance Bureau in 2018, many new and good drugs have been gradually transferred to the medical insurance catalog, which has achieved a significant expansion of the scope and level of medical insurance coverage.
The National Medical Insurance Bureau mentioned that in recent years, China's medical security industry has developed rapidly, and the National Medical Insurance Drug List has been dynamically adjusted every year. In the past
four years, more than 500 new and good drugs have been included in the list
, and drug prices have been greatly reduced after negotiation. The National Medical Insurance Drug List The support capacity and level of medical insurance have not been as good as before, and the local supplementary drugs can basically be better replaced by the drugs in the national catalog. It is not meaningful to continue to retain the local supplementary drugs. Uniformity, fairness and balance.
According to the National Medical Insurance Administration, as of June 30 this year,
15 provinces across the country and the Xinjiang Production and Construction Corps have completed the "digestion" task of all local supplementary drugs in advance
, and the remaining 16 provinces, including Beijing, have "digested" drugs. The completion date is the end of this year.
That is to say, by the end of 2022, all provinces in the country will complete the "digestion" of local supplementary drugs, and realize the basic uniformity of the scope of medical insurance nationwide.
On the whole, the progress of this work is stable and orderly, and
clinical and mass drug use are basically not affected
.
(Zhongxin Finance)